450 related articles for article (PubMed ID: 17123805)
21. Reciprocal control of 1,25-dihydroxyvitamin D and FGF23 formation involving the FGF23/Klotho system.
Prié D; Friedlander G
Clin J Am Soc Nephrol; 2010 Sep; 5(9):1717-22. PubMed ID: 20798257
[TBL] [Abstract][Full Text] [Related]
22. The Klotho gene family and the endocrine fibroblast growth factors.
Kurosu H; Kuro-o M
Curr Opin Nephrol Hypertens; 2008 Jul; 17(4):368-72. PubMed ID: 18660672
[TBL] [Abstract][Full Text] [Related]
23. Deletion of the vitamin D receptor specifically in the parathyroid demonstrates a limited role for the receptor in parathyroid physiology.
Meir T; Levi R; Lieben L; Libutti S; Carmeliet G; Bouillon R; Silver J; Naveh-Many T
Am J Physiol Renal Physiol; 2009 Nov; 297(5):F1192-8. PubMed ID: 19692484
[TBL] [Abstract][Full Text] [Related]
24. Toward a better understanding of Klotho.
Nabeshima Y
Sci Aging Knowledge Environ; 2006 May; 2006(8):pe11. PubMed ID: 16672727
[TBL] [Abstract][Full Text] [Related]
25. Genetic models show that parathyroid hormone and 1,25-dihydroxyvitamin D3 play distinct and synergistic roles in postnatal mineral ion homeostasis and skeletal development.
Xue Y; Karaplis AC; Hendy GN; Goltzman D; Miao D
Hum Mol Genet; 2005 Jun; 14(11):1515-28. PubMed ID: 15843402
[TBL] [Abstract][Full Text] [Related]
26. Vitamin D and phosphate regulate fibroblast growth factor-23 in K-562 cells.
Ito M; Sakai Y; Furumoto M; Segawa H; Haito S; Yamanaka S; Nakamura R; Kuwahata M; Miyamoto K
Am J Physiol Endocrinol Metab; 2005 Jun; 288(6):E1101-9. PubMed ID: 15671080
[TBL] [Abstract][Full Text] [Related]
27. Regulatory mechanisms of circulating fibroblast growth factor 23 in parathyroid diseases.
Imanishi Y; Kobayashi K; Kawata T; Inaba M; Nishizawa Y
Ther Apher Dial; 2007 Oct; 11 Suppl 1():S32-7. PubMed ID: 17976083
[TBL] [Abstract][Full Text] [Related]
28. Vitamin D signaling in osteocytes: effects on bone and mineral homeostasis.
Lieben L; Carmeliet G
Bone; 2013 Jun; 54(2):237-43. PubMed ID: 23072922
[TBL] [Abstract][Full Text] [Related]
29. Effects of calcium and of the Vitamin D system on skeletal and calcium homeostasis: lessons from genetic models.
Goltzman D; Miao D; Panda DK; Hendy GN
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):485-9. PubMed ID: 15225825
[TBL] [Abstract][Full Text] [Related]
30. Deletion of deoxyribonucleic acid binding domain of the vitamin D receptor abrogates genomic and nongenomic functions of vitamin D.
Erben RG; Soegiarto DW; Weber K; Zeitz U; Lieberherr M; Gniadecki R; Möller G; Adamski J; Balling R
Mol Endocrinol; 2002 Jul; 16(7):1524-37. PubMed ID: 12089348
[TBL] [Abstract][Full Text] [Related]
31. Premature aging in vitamin D receptor mutant mice.
Keisala T; Minasyan A; Lou YR; Zou J; Kalueff AV; Pyykkö I; Tuohimaa P
J Steroid Biochem Mol Biol; 2009 Jul; 115(3-5):91-7. PubMed ID: 19500727
[TBL] [Abstract][Full Text] [Related]
32. Intestinal calcium absorption: Molecular vitamin D mediated mechanisms.
Bouillon R; Van Cromphaut S; Carmeliet G
J Cell Biochem; 2003 Feb; 88(2):332-9. PubMed ID: 12520535
[TBL] [Abstract][Full Text] [Related]
33. Maternal hypervitaminosis D reduces fetal bone mass and mineral acquisition and leads to neonatal lethality.
Lieben L; Stockmans I; Moermans K; Carmeliet G
Bone; 2013 Nov; 57(1):123-31. PubMed ID: 23895994
[TBL] [Abstract][Full Text] [Related]
34. Effect of a transcriptional inactive or absent vitamin D receptor on beta-cell function and glucose homeostasis in mice.
Vangoitsenhoven R; Wolden-Kirk H; Lemaire K; Verstuyf A; Verlinden L; Yamamoto Y; Kato S; Van Lommel L; Schuit F; Van der Schueren B; Mathieu C; Overbergh L
J Steroid Biochem Mol Biol; 2016 Nov; 164():309-317. PubMed ID: 26877201
[TBL] [Abstract][Full Text] [Related]
35. Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidism.
Kawata T; Imanishi Y; Kobayashi K; Miki T; Arnold A; Inaba M; Nishizawa Y
J Am Soc Nephrol; 2007 Oct; 18(10):2683-8. PubMed ID: 17855636
[TBL] [Abstract][Full Text] [Related]
36. Genetic ablation of vitamin D activation pathway reverses biochemical and skeletal anomalies in Fgf-23-null animals.
Sitara D; Razzaque MS; St-Arnaud R; Huang W; Taguchi T; Erben RG; Lanske B
Am J Pathol; 2006 Dec; 169(6):2161-70. PubMed ID: 17148678
[TBL] [Abstract][Full Text] [Related]
37. Associations of vitamin D receptor, calcium-sensing receptor and parathyroid hormone gene polymorphisms with calcium homeostasis and peripheral bone density in adult Finns.
Laaksonen MM; Outila TA; Karkkainen MU; Kemi VE; Rita HJ; Perola M; Valsta LM; Lamberg-Allardt CJ
J Nutrigenet Nutrigenomics; 2009; 2(2):55-63. PubMed ID: 19690432
[TBL] [Abstract][Full Text] [Related]
38. Defective female reproductive function in 1,25(OH)2D-deficient mice results from indirect effect mediated by extracellular calcium and/or phosphorus.
Sun W; Xie H; Ji J; Zhou X; Goltzman D; Miao D
Am J Physiol Endocrinol Metab; 2010 Dec; 299(6):E928-35. PubMed ID: 20807842
[TBL] [Abstract][Full Text] [Related]
39. Vitamin D receptor: molecular signaling and actions of nutritional ligands in disease prevention.
Haussler MR; Haussler CA; Bartik L; Whitfield GK; Hsieh JC; Slater S; Jurutka PW
Nutr Rev; 2008 Oct; 66(10 Suppl 2):S98-112. PubMed ID: 18844852
[TBL] [Abstract][Full Text] [Related]
40. Targeted overexpression of vitamin D receptor in osteoblasts increases calcium concentration without affecting structural properties of bone mineral crystals.
Misof BM; Roschger P; Tesch W; Baldock PA; Valenta A; Messmer P; Eisman JA; Boskey AL; Gardiner EM; Fratzl P; Klaushofer K
Calcif Tissue Int; 2003 Sep; 73(3):251-7. PubMed ID: 14667138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
